- Home
- FMS vs ESTC Comparison
FMS vs ESTC Comparison
Compare FMS & ESTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMS
- ESTC
- Stock Information
- Founded
- FMS 1996
- ESTC 2012
- Country
- FMS Germany
- ESTC Netherlands
- Employees
- FMS N/A
- ESTC N/A
- Industry
- FMS Misc Health and Biotechnology Services
- ESTC Computer Software: Prepackaged Software
- Sector
- FMS Health Care
- ESTC Technology
- Exchange
- FMS Nasdaq
- ESTC Nasdaq
- Market Cap
- FMS 15.9B
- ESTC N/A
- IPO Year
- FMS 1996
- ESTC 2018
- Fundamental
- Price
- FMS $28.46
- ESTC $84.04
- Analyst Decision
- FMS Hold
- ESTC Buy
- Analyst Count
- FMS 1
- ESTC 26
- Target Price
- FMS $30.00
- ESTC $115.74
- AVG Volume (30 Days)
- FMS 395.6K
- ESTC 1.9M
- Earning Date
- FMS 07-29-2025
- ESTC 05-29-2025
- Dividend Yield
- FMS 1.99%
- ESTC N/A
- EPS Growth
- FMS 27.83
- ESTC N/A
- EPS
- FMS 2.28
- ESTC N/A
- Revenue
- FMS $21,068,786,202.00
- ESTC $1,483,296,000.00
- Revenue This Year
- FMS $2.74
- ESTC $14.68
- Revenue Next Year
- FMS $3.60
- ESTC $12.40
- P/E Ratio
- FMS $25.09
- ESTC N/A
- Revenue Growth
- FMS 0.10
- ESTC 17.04
- 52 Week Low
- FMS $17.93
- ESTC $69.00
- 52 Week High
- FMS $30.46
- ESTC $123.96
- Technical
- Relative Strength Index (RSI)
- FMS 51.55
- ESTC 45.88
- Support Level
- FMS $26.16
- ESTC $80.50
- Resistance Level
- FMS $28.23
- ESTC $84.66
- Average True Range (ATR)
- FMS 0.35
- ESTC 2.67
- MACD
- FMS -0.10
- ESTC 0.01
- Stochastic Oscillator
- FMS 63.92
- ESTC 42.20
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.